Ameriprise
GLSI icon

Ameriprise’s Greenwich LifeSciences GLSI Stock Holding History

Ameriprise’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-53,647
Closed -$564K – 3906
2023
Q4 		$564K Sell
53,647
-9,757
-15% -$97.8K ﹤0.01% 3411
2023
Q3 		$560K Sell
63,404
-4,788
-7% -$45K ﹤0.01% 3364
2023
Q2 		$658K Buy
68,192
+2,584
+4% +$28.9K ﹤0.01% 3338
2023
Q1 		$905K Sell
65,608
-42
-0.1% -$666 ﹤0.01% 3202
2022
Q4 		$997K Buy
65,650
+3,949
+6% +$45.2K ﹤0.01% 3128
2022
Q3 		$561K Buy
61,701
+19,520
+46% +$181K ﹤0.01% 3347
2022
Q2 		$359K Sell
42,181
-526
-1% -$6.03K ﹤0.01% 3510
2022
Q1 		$837K Buy
42,707
+13,839
+48% +$280K ﹤0.01% 3284
2021
Q4 		$701K Buy
28,868
+22,569
+358% +$755K ﹤0.01% 3404
2021
Q3 		$246K Buy
+6,299
New +$263K ﹤0.01% 3652

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Ameriprise's GLSI Position: Q1 2024 in Review

Ameriprise sold out of Greenwich LifeSciences (GLSI) in Q1 2024, closing a stake of 53,647 shares — an estimated $564K sold.

Ameriprise first reported a position in GLSI in Q3 2021 and held it in 10 quarters. The position peaked at $997K in Q4 2022. 31 funds tracked by Wall St. Rank hold GLSI as of Q1 2024.

  • Ameriprise reported no remaining Greenwich LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Ameriprise sold 53,647 Greenwich LifeSciences shares in Q1 2024, an estimated $564K.
  • Ameriprise first reported a position in Greenwich LifeSciences in Q3 2021 and held it in 10 quarters.
  • Ameriprise's Greenwich LifeSciences position peaked at $997K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2024.

Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.